BlueCrest Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,226	Closed	-$846K	–	356
2021 Q2	$846K	Buy	+5,226	New	+$846K	0.02%	356